Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial.
van Veldhuisen
Dirk J
DJ
McMurray
John J V
JJ
D004921:Erythropoietin / Q000096:biosynthesis* / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D016896:Treatment Outcome
D004921:Erythropoietin